Requiring the Secretary of Health and Mental Hygiene to establish specified guidelines for the co-prescribing of opioid overdose reversal drugs that are applicable to all licensed health care providers in the State who are authorized to prescribe monitored prescription drugs; requiring the guidelines to address the co-prescribing of opioid overdose reversal drugs for specified patients; etc.
Bill File Type: Regular
Effective Date(s): June 1, 2017
( 13-3401, 13-3402 )
Last Updated: 2/3/2020 2:35 PM